| scholarly article | Q13442814 |
| P50 | author | Mitchell K.p. Lai | Q43120264 |
| P2093 | author name string | J Lee | |
| S H Brown | |||
| S Roman | |||
| A D Medhurst | |||
| J C Roberts | |||
| C P L-H Chen | |||
| P2860 | cites work | Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease | Q48318802 |
| A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas | Q48369562 | ||
| Neuronal histamine deficit in Alzheimer's disease | Q48534393 | ||
| Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. | Q48899369 | ||
| Brain histamine in Alzheimer's disease | Q48942856 | ||
| Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. | Q51974299 | ||
| Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients | Q69597522 | ||
| ??? | Q28299003 | ||
| The histamine H3 receptor: an attractive target for the treatment of cognitive disorders | Q24654788 | ||
| Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist | Q24671207 | ||
| “Mini-mental state” | Q25938989 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Modulation of neurotransmitter release via histamine H3 heteroreceptors | Q28244199 | ||
| Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system | Q28271866 | ||
| The cholinergic hypothesis of geriatric memory dysfunction | Q28277644 | ||
| The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders | Q28292033 | ||
| GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models | Q28574369 | ||
| The physiology of brain histamine. | Q31875011 | ||
| Behaviour changes in dementia. 1: Point of entry data of a prospective study | Q32149090 | ||
| Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes | Q33204916 | ||
| Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease | Q33303418 | ||
| Clinical neurochemistry: developments in dementia research based on brain bank material | Q33464724 | ||
| Asymmetry of pathology in Alzheimer's disease | Q33629641 | ||
| Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. | Q34049885 | ||
| Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 | ||
| Perspectives on cognitive domains, H3 receptor ligands and neurological disease | Q34355156 | ||
| Histamine function in brain disorders | Q34407502 | ||
| BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology | Q34569432 | ||
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias | Q35085187 | ||
| Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease | Q38298139 | ||
| Glutamate transmission and toxicity in Alzheimer's disease | Q39469481 | ||
| High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain | Q42463002 | ||
| Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats | Q42581834 | ||
| Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 | ||
| Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease | Q44438171 | ||
| [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution | Q44691364 | ||
| Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease | Q45155062 | ||
| Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains | Q45194006 | ||
| Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. | Q46875721 | ||
| Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease | Q47406803 | ||
| Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study | Q47604140 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 130-138 | |
| P577 | publication date | 2009-02-16 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice | |
| P478 | volume | 157 |
| Q43110514 | Advances in histamine pharmacology reveal new drug targets |
| Q28542876 | Assessment of [125I]WYE-230949 as a novel histamine H3 receptor radiopharmaceutical |
| Q37737296 | Current therapeutic targets for the treatment of Alzheimer's disease |
| Q28276862 | Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer's Disease |
| Q47730256 | Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease. |
| Q30462161 | Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse |
| Q33909909 | Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes |
| Q37420711 | Ligand autoradiographical quantification of histamine H3 receptor in human dementia with Lewy bodies |
| Q38809649 | Monoaminergic neuropathology in Alzheimer's disease |
| Q38286222 | Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets. |
| Q84679904 | Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of |
| Q42691812 | The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats |
| Q38107173 | The neglected role of histamine in Alzheimer's disease. |
| Q49672905 | Therapeutics of Neurotransmitters in Alzheimer's Disease |
Search more.